Eight-patient Parkinson's stem cell clinical trial confirms feasibility

A landmark survey led by Lund, Sweden, has shown that transplanting stem cell-derived dopamine progenitor cells into the encephalon is feasible. Eight patients were transplanted successful the archetypal objective trial, and nary superior broadside effects linked to the transplanted cells were seen during the archetypal twelvemonth of follow-up. The results are published successful Nature Medicine.